ECTRIMS Virtual Congress 2021 – PONVORY In Patients With Relapsing Forms of Multiple Sclerosis

Dr. Allitia DiBernardo, MD, Global Head of Medical Affairs-Neuroscience at Janssen discusses a presentation at the 2021 European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) virtual congress titled “Ponesimod demonstrated increased clinical benefit over teriflunomide in early disease subgroup compared with overall population.” She talks about how this research may impact treatment decisions for early disease patients. 

With over 12 years of industry experience, and 22 years as a physician, Allitia is passionate about understanding and shining a light on the lived experiences of individuals with neurologic disorders. As the Global Head of Medial Affairs, Neurology at Janssen, Allitia has the honor of channeling that passion into leading an incredible team that is actively working to bring new therapies to patients with CNS disorders, leading the way in neurology research.

Liked it? Take a second to support healthprofessionalradio on Patreon!


Leave a Reply

You must be logged in to post a comment.